The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

Triptans is a medication that can help relieve migraine symptoms. Research has found it effective, but it’s not for everyone. Migraine is a neurological condition affecting millions of people ...

A drug recently approved to prevent migraine may start working right away ... Lipton, MD, of Albert Einstein College of Medicine in the Bronx, New York, and a Fellow of the American Academy ...

Teva’s migraine drug Ajovy (fremanezumab) has been approved in Europe ... The Israel-based company is in need of new revenues, and Ajovy is expected to bring in around $500 million a year ...

This is a common practice. However, since there are now new FDA-approved medications for migraine attacks, verapamil is rarely prescribed anymore. Verapamil is available in several dosage forms ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment ... Lipton, MD, of Albert Einstein College of Medicine in the Bronx, New York, in a press release.

The agency then approved the device for use in the treatment of migraine attacks in 2017 ... As a journalist, his work has focused on new research in the treatment of infectious diseases ...

But a recently approved daily migraine pill called Qulipta (atogepant ... from the very first day they started taking the drug, according to a new report in the journal Neurology.